Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.
O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffeine and the formation of some cancers.Edward L. Carter, "BYU scientist finds caffeine may keep cancer cells alive", Deseret News, Jan. 22, 1998
References
External links Short listing of O'Neill's credentials BYU bio Patent list for O'Neill Article by O'Neill on his discoveries potential